190 related articles for article (PubMed ID: 28167558)
1. Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.
Perin L; Moreira da Silva R; Fonseca KD; Cardoso JM; Mathias FA; Reis LE; Molina I; Correa-Oliveira R; Vieira PM; Carneiro CM
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167558
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.
de Jesus SM; Pinto L; Moreira FL; Nardotto GHB; Cristofoletti R; Perin L; Fonseca KDS; Barbêdo P; Bandeira LC; Vieira PMA; Carneiro CM
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168611
[TBL] [Abstract][Full Text] [Related]
5. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
[TBL] [Abstract][Full Text] [Related]
6. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.
Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290
[TBL] [Abstract][Full Text] [Related]
7. Rapid and sensitive ultra-high-pressure liquid chromatography method for quantification of antichagasic benznidazole in plasma: application in a preclinical pharmacokinetic study.
Davanço MG; de Campos ML; Peccinini RG
Biomed Chromatogr; 2015 Jul; 29(7):1008-15. PubMed ID: 25424984
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of benznidazole in adult patients with Chagas disease.
Soy D; Aldasoro E; Guerrero L; Posada E; Serret N; Mejía T; Urbina JA; Gascón J
Antimicrob Agents Chemother; 2015; 59(6):3342-9. PubMed ID: 25824212
[TBL] [Abstract][Full Text] [Related]
9. Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.
Marsón ME; Dana DD; Altcheh J; García-Bournissen F; Mastrantonio G
J Clin Lab Anal; 2013 Sep; 27(5):384-90. PubMed ID: 24038224
[TBL] [Abstract][Full Text] [Related]
10. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.
Rial MS; Scalise ML; López Alarcón M; Esteva MI; Búa J; Benatar AF; Prado NG; Riarte AR; Fichera LE
Parasitology; 2019 Mar; 146(3):305-313. PubMed ID: 30301480
[TBL] [Abstract][Full Text] [Related]
11. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease.
Guerrero L; Pinazo MJ; Posada E; Gascón J; Ribas J; Soy D
Clin Chem Lab Med; 2011 Jan; 49(1):77-82. PubMed ID: 21083440
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
Altcheh J; Moscatelli G; Mastrantonio G; Moroni S; Giglio N; Marson ME; Ballering G; Bisio M; Koren G; García-Bournissen F
PLoS Negl Trop Dis; 2014 May; 8(5):e2907. PubMed ID: 24853169
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
Molina-Morant D; Fernández ML; Bosch-Nicolau P; Sulleiro E; Bangher M; Salvador F; Sanchez-Montalva A; Ribeiro ALP; de Paula AMB; Eloi S; Correa-Oliveira R; Villar JC; Sosa-Estani S; Molina I
Trials; 2020 Apr; 21(1):328. PubMed ID: 32293523
[TBL] [Abstract][Full Text] [Related]
14. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
[TBL] [Abstract][Full Text] [Related]
15. Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.
Morilla MJ; Montanari JA; Prieto MJ; Lopez MO; Petray PB; Romero EL
Int J Pharm; 2004 Jul; 278(2):311-8. PubMed ID: 15196636
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials.
Molina I; Salvador F; Sánchez-Montalvá A; Artaza MA; Moreno R; Perin L; Esquisabel A; Pinto L; Pedraz JL
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167552
[TBL] [Abstract][Full Text] [Related]
17. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
[TBL] [Abstract][Full Text] [Related]
18. Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.
Moreira da Silva R; Oliveira LT; Silva Barcellos NM; de Souza J; de Lana M
Antimicrob Agents Chemother; 2012 Jun; 56(6):3344-8. PubMed ID: 22450981
[TBL] [Abstract][Full Text] [Related]
19. Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.
Perin L; Fonseca KDS; de Carvalho TV; Carvalho LM; Madeira JV; Medeiros LDF; Molina I; Correa-Oliveira R; Carneiro CM; Vieira PMA
Exp Parasitol; 2020 Mar; 210():107834. PubMed ID: 31978394
[TBL] [Abstract][Full Text] [Related]
20. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
